Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Modulation of CYP450 activities in patients with type 2 diabetes.

Gravel S, Chiasson JL, Turgeon J, Grangeon A, Michaud V.

Clin Pharmacol Ther. 2019 May 17. doi: 10.1002/cpt.1496. [Epub ahead of print]

PMID:
31099895
2.

Nitrogen-doped graphene stabilized copper nanoparticles for Huisgen [3+2] cycloaddition "click" chemistry.

Siva Prasanna Sanka RV, K B, Leterrier Y, Pandey S, Srivastava M, Srivastava A, Binder WH, Rana S, Michaud V.

Chem Commun (Camb). 2019 May 14. doi: 10.1039/c9cc02057h. [Epub ahead of print]

PMID:
31086878
3.

Use of 4β-hydroxycholesterol plasma concentrations as an endogenous biomarker of CYP3A activity: Clinical validation in individuals with type 2 diabetes.

Gravel S, Chiasson JL, Gaudette F, Turgeon J, Michaud V.

Clin Pharmacol Ther. 2019 Apr 19. doi: 10.1002/cpt.1472. [Epub ahead of print]

PMID:
31002385
4.

Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine.

Clermont V, Grangeon A, Barama A, Turgeon J, Lallier M, Malaise J, Michaud V.

Br J Clin Pharmacol. 2019 Feb 28. doi: 10.1111/bcp.13908. [Epub ahead of print]

PMID:
30817016
5.

Microstructured Fibers for the Production of Food.

Sordo F, Janecek ER, Qu Y, Michaud V, Stellacci F, Engmann J, Wooster TJ, Sorin F.

Adv Mater. 2019 Apr;31(14):e1807282. doi: 10.1002/adma.201807282. Epub 2019 Feb 15.

PMID:
30767332
6.

Development of a selective and sensitive high-performance liquid chromatography-tandem mass spectrometry assay to support pharmacokinetic studies of LY-487,379 in rat and marmoset.

Gaudette F, Hamadjida A, Bédard D, Nuara SG, Gourdon JC, Michaud V, Beaudry F, Huot P.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Sep 1;1093-1094:1-7. doi: 10.1016/j.jchromb.2018.06.036. Epub 2018 Jun 19.

PMID:
29980099
7.

Effects of a Series of Acidic Drugs on L-Lactic Acid Transport by the Monocarboxylate Transporters MCT1 and MCT4.

Leung YH, Belanger F, Lu J, Turgeon J, Michaud V.

Curr Pharm Biotechnol. 2017;18(14):1141-1150. doi: 10.2174/1389201019666180308091504.

PMID:
29521223
8.

Development and validation of probe drug cocktails for the characterization of CYP450-mediated metabolism by human heart microsomes.

Huguet J, Gaudette F, Michaud V, Turgeon J.

Xenobiotica. 2019 Feb;49(2):187-199. doi: 10.1080/00498254.2018.1438684. Epub 2018 Mar 8.

PMID:
29448869
9.

Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case-control pharmacokinetic study.

Gravel S, Chiasson JL, Dallaire S, Turgeon J, Michaud V.

BMJ Open. 2018 Feb 8;8(2):e020922. doi: 10.1136/bmjopen-2017-020922.

10.

Study of Statin- and Loratadine-Induced Muscle Pain Mechanisms Using Human Skeletal Muscle Cells.

Leung YH, Turgeon J, Michaud V.

Pharmaceutics. 2017 Oct 10;9(4). pii: E42. doi: 10.3390/pharmaceutics9040042.

11.

Effect of mechanical damage and wound healing on the viscoelastic properties of stems of flax cultivars (Linum usitatissimum L. cv. Eden and cv. Drakkar).

Paul-Victor C, Dalle Vacche S, Sordo F, Fink S, Speck T, Michaud V, Speck O.

PLoS One. 2017 Oct 5;12(10):e0185958. doi: 10.1371/journal.pone.0185958. eCollection 2017.

12.

The Dangers of Polypharmacy in Elderly Patients.

Turgeon J, Michaud V, Steffen L.

JAMA Intern Med. 2017 Oct 1;177(10):1544. doi: 10.1001/jamainternmed.2017.4790. No abstract available.

PMID:
28973278
13.
14.

Highly sensitive LC-MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human.

Grangeon A, Gravel S, Gaudette F, Turgeon J, Michaud V.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Jan 1;1040:144-158. doi: 10.1016/j.jchromb.2016.12.006. Epub 2016 Dec 6.

PMID:
27978469
15.

Clinical decision support systems: great promises for better management of patients' drug therapy.

Turgeon J, Michaud V.

Expert Opin Drug Metab Toxicol. 2016 Sep;12(9):993-5. doi: 10.1517/17425255.2016.1171317. Epub 2016 Apr 11. No abstract available. Erratum in: Expert Opin Drug Metab Toxicol. 2016 Sep;12 (9):iii.

PMID:
27021287
16.

Evaluation of Limited Sampling Methods for Oral Busulfan Pharmacokinetic Monitoring in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.

Bouchard P, Bilodeau S, Alain K, Vadnais B, Franco M, Turgeon J, Michaud V.

Ther Drug Monit. 2016 Jun;38(3):414-8. doi: 10.1097/FTD.0000000000000280.

PMID:
26829598
17.

Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry.

Gaudette F, Sirhan-Daneau A, St-Onge M, Turgeon J, Michaud V.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 1;1008:174-180. doi: 10.1016/j.jchromb.2015.11.035. Epub 2015 Nov 23.

PMID:
26655109
18.

Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy.

Shaw K, Amstutz U, Kim RB, Lesko LJ, Turgeon J, Michaud V, Hwang S, Ito S, Ross C, Carleton BC; CPNDS Clinical Recommendation Group.

Ther Drug Monit. 2015 Aug;37(4):428-36. doi: 10.1097/FTD.0000000000000192. Review.

19.

Effects of β-blockers and tricyclic antidepressants on the activity of human organic anion transporting polypeptide 1A2 (OATP1A2).

Lu J, Michaud V, Moya LG, Gaudette F, Leung YH, Turgeon J.

J Pharmacol Exp Ther. 2015 Mar;352(3):552-8. doi: 10.1124/jpet.114.219287. Epub 2015 Jan 6.

PMID:
25563901
20.

A toolbox of oligopeptide-modified polymers for tailored elastomers.

Croisier E, Liang S, Schweizer T, Balog S, Mionić M, Snellings R, Cugnoni J, Michaud V, Frauenrath H.

Nat Commun. 2014 Sep 8;5:4728. doi: 10.1038/ncomms5728.

PMID:
25198134

Supplemental Content

Loading ...
Support Center